Filter
441
Filtered Results: 441
Text search:
pharmacokinetics
Featured
Recommendations
56
New Publications
89
Language
Document type
No document type
230
Guidelines
102
Studies & Reports
66
Manuals
20
Training Material
8
Fact sheets
7
Strategic & Response Plan
6
Situation Updates
1
Online Courses
1
Countries / Regions
India
24
Global
13
Ethiopia
12
Kenya
8
Latin America and the Carribbean
8
South Africa
7
Russia
7
Africa
6
Western and Central Europe
6
Sierra Leone
5
Zimbabwe
5
Germany
5
Bangladesh
5
Uganda
5
Zambia
5
Ghana
4
Eastern Europe
4
Brazil
4
Namibia
4
Ukraine
3
Rwanda
3
Nigeria
3
Tanzania
3
South–East Asia Region
3
East and Southern Africa
3
Argentina
3
Liberia
3
Thailand
2
Cameroon
2
Cambodia
2
West and Central Africa
2
Paraguay
2
Eswatini/ Swaziland
2
Nepal
1
Lesotho
1
Australia
1
Syria
1
Burkina Faso
1
Philippines
1
Mozambique
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
North America
1
Denmark
1
Sri Lanka
1
Sudan
1
Angola
1
Botswana
1
South Sudan
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
121
Clinical Guidelines
101
Public Health
19
Women & Child Health
17
Capacity Building
4
Pharmacy & Technologies
3
Key Resources
2
Toolboxes
TB
68
HIV
58
AMR
37
Mental Health
25
Pharmacy
25
NTDs
23
COVID-19
17
Malaria
14
Ebola & Marburg
12
NCDs
10
Refugee
6
Planetary Health
6
Rapid Response
5
Caregiver
5
Disability
3
Polio
2
Global Health Education
2
Natural Hazards
1
Conflict
1
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
African Health Sciences 2013; 13(2): 219 - 232 http://dx.doi.org/10.4314/ahs.v13i2.4
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб...
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
Fourth Edition
These Guidelines on prudent use of antimicrobials in human health are based on a technical report prepared by the European Centre for Disease Prevention and Control (ECDC) with input from EU Member States experts and stakeholders, which should be referred to for details of the methodology used in cr...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
Published: February 23, 2010
https://doi.org/10.1371/journal.pmed.1000235
Volume 7 | Issue 2 | e1000235
Accessed Febr. 6, 2020
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,...
Women and Health Initiative Working Paper No. 1. Women and Health Initiative
Improving maternal health in the context of the sub-Saharan African HIV epidemic requires greater understanding of the relationships between HIV disease and maternal morbidity and mortality, integrated and effective resp...
Improving maternal health in the context of the sub-Saharan African HIV epidemic requires greater understanding of the relationships between HIV disease and maternal morbidity and mortality, integrated and effective resp...
The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO CIA List supports strategies to mitigate the human health risks associated with antimicrobial use in ...
